Skip to main content
. 2017 Jul 24;152(2):195–206. doi: 10.1111/imm.12780

Figure 2.

Figure 2

Reverse vaccinology 1·0. In the post‐genomic era, discovery of vaccine candidates is increasingly reliant on an integrated analysis of the genomic, transcriptomic and proteomic data sets. The targets that are prioritized through this approach are subsequently validated in the laboratory using in vitro assays, cohort studies and animal models before testing for immunogenicity and efficacy in humans.